Replies to post #2900 on Galectin Therapeutics Inc. (GALT)

[biotech2010]

Multiple companies have already passed on GALT when they purchased other companies-Allergan bought TBRA, NVS invested in CNAT, etc, etc, etc, why would you think there is someone else out there in the wings that would pay through the nose for a company that hasn't shown anything of real value?

I'm still a shareholder but understand it's either a positive CX trial or nothing, if you want to believe something else it's up to you.